Linguistic strategies for improving informed consent in clinical trials among low health literacy patients

Journal of the National Cancer Institute

Volumn 109, Issue 3, 2017, Pages

  Krieger, Janice L ^a   Neil, Jordan M ^a   Strekalova, Yulia A ^a   Sarge, Melanie A ^b,c  

^a UNIVERSITY OF FLORIDA   (United States)

^b Texas Tech University   (United States)

^c TEXAS TECH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFFECT; ANXIETY; ARTICLE; BEHAVIOR; BLADDER CANCER; BREAST CANCER; CANCER PATIENT; COGNITION; COLORECTAL CANCER; COMPREHENSION; CONTROLLED STUDY; FEMALE; FEMALE GENITAL TRACT CANCER; HEALTH LITERACY; HUMAN; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; LANGUAGE; LINGUISTICS; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; THEORETICAL MODEL; ADOLESCENT; AGED; CLINICAL TRIAL (TOPIC); GAMBLING; METABOLISM; MIDDLE AGED; NEOPLASMS; PATIENT EDUCATION; PROCEDURES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CLINICAL TRIALS AS TOPIC; COGNITION; COMPREHENSION; FEMALE; GAMBLING; HEALTH LITERACY; HUMANS; INFORMED CONSENT; LANGUAGE; LINGUISTICS; MALE; MIDDLE AGED; NEOPLASMS; PATIENT EDUCATION AS TOPIC; YOUNG ADULT;

EID: 85018190126     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djw233     Document Type: Article

References (43)

1. Byrne MM, Tannenbaum SL, Glück S, Hurley J, Antoni M. Participation in cancer clinical trials: Why are patients not participating?. Med Decis Mak. 2014; 34(1):116-126.
2. Jimenez R, Zhang B, Joffe S, et al. Clinical trial participation among ethnic/racial minority and majority patients with advanced cancer: What factors most influence enrollment?. J Palliat Med. 2013;16(3):256-262.
3. Institute of Medicine Forum on drug discovery, development, and translation. Transforming clinical research in the United States: Challenges and opportunities: Workshop summary. Washington, DC: National Academies Press; 2010. http://www.ncbi.nlm.nih.gov/books/NBK50892/. Accessed August 31, 2016.
4. Grand MM, O'Brien PC. Obstacles to participation in randomised cancer clinical trials: A systematic review of the literature. J Med Imaging Radiat Oncol. 2012;56(1):31-39.
5. Jenkins V, Fallowfield L. Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy. Br J Cancer. 2000;82(11): 1783-1788.
6. Davis TC, Holcombe RF, Berkel HJ, Pramanik S, Divers SG. Informed consent for clinical trials: A comparative study of standard versus simplified forms. J Natl Cancer Inst. 1998;90(9):668-674.
7. Howard L, de Salis I, Tomlin Z, Thornicroft G, Donovan J. Why is recruitment to trials difficult? An investigation into recruitment difficulties in an RCT of supported employment in patients with severe mental illness. Contemp Clin Trials. 2009;30(1):40-46.
8. Krieger JL, Parrott RL, Nussbaum JF. Metaphor use and health literacy: A pilot study of strategies to explain randomization in cancer clinical trials. J Health Commun. 2011;16(1):3-16.
9. Krieger JL. Last resort or roll of the die? Exploring the role of metaphors in cancer clinical trials education among medically underserved populations. J Health Commun. 2014;19(10):1161-1177.
10. Galesic M, Garcia-Retamero R. Using analogies to communicate information about health risks. Appl Cogn Psychol. 2013;27(1):33-42.
11. Palmer-Wackerly AL, Krieger JL. Dancing around infertility: The use of metaphors in a complex medical situation. Health Commun. 2015;30(6):612-623.
12. Parrott R, Smith RA. Defining genes using "blueprint" versus "instruction" metaphors: Effects for genetic determinism, response efficacy, and perceived control. Health Commun. 2014;29(2):137-146.
13. Stableford S, Mettger W. Plain language: A strategic response to the health literacy challenge. J Public Health Policy. 2007;28(1):71-93.
14. Holmes-Rovner M, Stableford S, Fagerlin A, et al. Evidence-based patient choice: A prostate cancer decision aid in plain language. BMC Med Inform Decis Mak. 2005;5:16.
15. Davis TC, Williams MV, Marin E, Parker RM, Glass J. Health literacy and cancer communication. CA Cancer J Clin. 2002;52(3):134-149.
16. Jenkins V, Leach L, Fallowfield L, Nicholls K, Newsham A. Describing randomisation: Patients' and the public's preferences compared with clinicians' practice. Br J Cancer. 2002;87(8):854-858.
17. Anghelcev G, Sar S. The influence of pre-existing audience mood and message relevance on the effectiveness of health PSAs: Differential effects by message type. Journal Mass Commun Q. 2011;88(3):481-501.
18. Frew PM, Hou SI, Davis M, et al. The likelihood of participation in clinical trials can be measured: The Clinical Research Involvement Scales (CRIS). J Clin Epidemiol. 2010;63(10):1110-1117.
19. Celsi RL, Olson JC. The role of involvement in attention and comprehension processes. J Consum Res. 1988;15(2):210-224.
20. MacLeod C, Rutherford EM. Anxiety and the selective processing of emotional information: Mediating roles of awareness, trait and state variables, and personal relevance of stimulus materials. Behav Res Ther. 1992;30(5):479-491.
21. Jenkins V, Fallowfield L. Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy. Br J Cancer. 2000;82(11):1783-1788.
22. Jenkins VA, Anderson JL, Fallowfield LJ. Communication and informed consent in phase 1 trials: A review of the literature from January 2005 to July 2009. Support Care Cancer. 2010;18(9):1115-1121.
23. Llewellyn-Thomas HA, McGreal MJ, Thiel EC, Fine S, Erlichman C. Patients' willingness to enter clinical trials: Measuring the association with perceived benefit and preference for decision participation. Soc Sci Med. 1991;32(1): 35-42.
24. Penman DT, Holland JC, Bahna GF, et al. Informed consent for investigational chemotherapy: Patients' and physicians' perceptions. J Clin Oncol. 1984;2(7): 849-855.
25. Ajzen I. Theories of cognitive self-regulation: The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50(2):179-211.
26. Petty RE, Cacioppo JT. Attitudes and persuasion: Classic and contemporary approaches. Vol. xvii. Boulder, CO: Westview Press; 1996.
27. McCaffery K, Wardle J, Waller J. Knowledge, attitudes, and behavioral intentions in relation to the early detection of colorectal cancer in the United Kingdom. Prev Med. 2003;36(5):525-535.
28. Hu Y, Sundar SS. Effects of online health sources on credibility and behavioral intentions. Commun Res. 2009. http://crx.sagepub.com/content/early/ 2009/11/25/0093650209351512. Accessed August 31, 2016.
29. Schneider A, Andrade J, Tanja-Dijkstra K, White M, Moles DR. The psychological cycle behind dental appointment attendance: A cross-sectional study of experiences, anticipations, and behavioral intentions. Community Dent Oral Epidemiol. 2016;44(4):364-730.
30. Health Information National Trends Survey, Instruments. http://hints. cancer.gov/instrument.aspx. Accessed August 31, 2016.
31. Richardson A, Allen JA, Xiao H, Vallone D. Effects of race/ethnicity and socioeconomic status on health information-seeking, confidence, and trust. J Health Care Poor Underserved. 2012;23(4):1477-1493.
32. Lee T, Mathis A, Dutton M. An examination of early colorectal cancer screening guidelines for African Americans: Hints from the HINTS data. J Health Disparities Res Pract. 2016;31:9(1). http://digitalscholarship.unlv.edu/jhdrp/ vol9/iss1/10. Accessed August 31, 2016.
33. Witte K. Predicting risk behaviors: Development and validation of a diagnostic scale. J Health Commun. 1996;1(4):317-42.
34. Health Information National Trends Survey 4 Cycle 3 Methodology Report. http://hints.cancer.gov/docs/Instruments/HINTS-4-Cycle-3-English-Annotated-508c-3-21-2014.pdf. Accessed August 31, 2016.
35. Curbow B, Fogarty LA, McDonnell K, Chill J, Scott LB. Can a brief video intervention improve breast cancer clinical trial knowledge and beliefs?. Soc Sci Med. 2004;58(1):193-205.
36. Wells W, Leavitt C, Mcconville M. Reaction profile for TV commercials. J Advert Res. 1971;11(6):11-17.
37. Nabi RL. A cognitive-functional model for the effects of discrete negative emotions on information processing, attitude change, and recall. Commun Theory. 1999;9(3):292-320.
38. Krieger JL, Parrott RL, Nussbaum JF. Metaphor use and health literacy: A pilot study of strategies to explain randomization in cancer clinical trials. J Health Commun. 2010;16(1):3-16.
39. Hayes A. An Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach. New York: Guilford Press; 2013.
40. Hayes AF, Preacher KJ. Statistical mediation analysis with a multicategorical independent variable. Br J Math Stat Psychol. 2014;67(3):451-470.
41. Hayes A. Supplementary PROCESS documentation. http://afhayes.com/ public/docaddendum.pdf. Accessed August 31, 2016.
42. Diviani N, van den Putte B, Giani S, van Weert JC. Low health literacy and evaluation of online health information: A systematic review of the literature. J Med Internet Res. 2015;17(5):e112.
43. Wade J, Donovan JL, Lane JA, Neal DE, Hamdy FC. It's not just what you say, it's also how you say it: Opening the "black box" of informed consent appointments in randomised controlled trials. Soc Sci Med. 2009;68(11): 2018-2028